Clinical Trials
GlycoMimetics completes enrollment in Phase 2 study of GMI-1070
Clinical-stage biotechnology company GlycoMimetics has completed patient enrollment for the Phase 2 sickle cell disease study evaluating GMI-1070. Hospitalized sickle...
Clinical Trials
Kiadis Pharma raises fund for Phase II study of ATIR
Kiadis Pharma has raised EUR10m in a financing round to conduct Phase II study of a cell based medicinal product candidate, ATIR, and to...
Clinical Trials
Pfizer Phase 3 fibromyalgia study of pregabalin meets primary endpoint
Pfizer Phase III study of pregabalin controlled-release (CR) formulation has met primary endpoint of time to loss of therapeutic response (LTR), in fibromyalgia patients....
Clinical Trials
Idera completes patient enrollment in Phase 2 trial of IMO-3100
Idera Pharmaceuticals has concluded enrolling patients in double-blind, placebo-controlled Phase 2 trial assessing IMO-3100 in psoriasis patients. The study randomized...
Clinical Trials
Novavax pandemic influenza vaccine meets endpoints in two Phase 1 trials
Novavax A/H5N1 avian influenza vaccine candidate has met safety and immunogenicity endpoints in two Phase 1 clinical trials. The trials...
Clinical Trials
Hybrigenics starts phase II clinical trial of inecalcitol in chronic lymphocytic leukemia
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new treatments against proliferative diseases,...
Clinical Trials
Millennium begins pharmacogenetics clinical outcomes study
Millennium Laboratories has commenced clinical outcomes study of its pharmacogenetic test. As part of the study, Millennium will evaluate the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.